Compound information
- Natural Products
- ZC745458
- Molecular Formula
- C24H37N3O7
- Molecular Weight
- 479.263150524 g/mol
- Structure
-
- IUPAC Name
- methyl (2S)-2-[[(2R)-2-[[(2R)-2-(benzyloxycarbonylamino)-4-methyl-pentanoyl]amino]-4-methyl-pentanoyl]amino]-3-hydroxy-propanoate
- InChI
- InChI=1S/C24H37N3O7/c1-15(2)11-18(21(29)26-20(13-28)23(31)33-5)25-22(30)19(12-16(3)4)27-24(32)34-14-17-9-7-6-8-10-17/h6-10,15-16,18-20,28H,11-14H2,1-5H3,(H,25,30)(H,26,29)(H,27,32)/t18-,19-,20+/m1/s1
- InChI Key
- HOAXIMHIEYHJHL-AQNXPRMDSA-N
- SMILES
- COC(=O)[C@H](CO)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCc1ccccc1
- Source
- ZINC000005028481
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 34 | Ring Count | 1 |
Heteroatom Count | 10 | Rotatable Bond Count | 13 |
Hydrogen Bond Acceptor Count | 7 | Hydrogen Bond Donor Count | 4 |
Topological Polar Surface Area | 143.06 Å2 | LogP | 2.813 |
LogS | -4.079 | LogD | 3.526 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.851 | Pgp substrate | 0.121 |
HIA | 0.956 | F20 % | 0.985 |
F30 % | 0.005 | Caco-2 | -5.25 |
MDCK | -5.169 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.1 | PPB | 57.323 |
VD | 0.795 | Fu | 1.345 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.606 |
CYP2A6 substrate | 0.296 | CYP2B6 substrate | 0.406 |
CYP2C19 inhibitor | 0.619 | CYP2C19 substrate | 0.822 |
CYP2C8 substrate | 0.609 | CYP2C9 inhibitor | 0.427 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.01 |
CYP2D6 substrate | 0.321 | CYP2E1 substrate | 0.291 |
CYP3A4 inhibitor | 0.348 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.876 | CL | 6.868 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.005 | Hepatotoxicity | 0.673 |
Mutagenicity | 0.421 | Rat Oral Acute Toxicity | 0.213 |
FDAMDD | 0.061 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.005 | Eye Corrosion | 0.004 |
Eye Irritation | 0.012 | Respiratory Toxicity | 0.002 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.502 | IGC50 | 2.71 |
LC50FM | 3.719 | LC50DM | 4.731 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.24 | NR-AR-LBD | 0.33 |
NR-AhR | 0.003 | NR-Aromatase | 0.039 |
NR-ER | 0.364 | NR-ER-LBD | 0.372 |
NR-PPAR-gamma | 0.271 | SR-ARE | 0.468 |
SR-ATAD5 | 0.327 | SR-HSE | 0.073 |
SR-MMP | 0.022 | SR-p53 | 0.052 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.